Similar survival, but better quality of life after myeloablative transplantation using unrelated cor

来源 :The 35th World Congress of the International Society of Hema | 被引量 : 0次 | 上传用户：zzzj1019

【摘要】

：

【作者】

：

Hui-lan Liu Liang-quan Geng Xing-bing Wang Kai-yang Ding Juan Tong Bao-lin Tang Chen-yang Zhou Wen Yao Chang-cheng Zheng Kai-di Song Xiao-yu Zhu Zi-min Sun

【机构】

：

Department of Hematology of Anhui Provincial Hospital,Anhui Medical University

【出处】

：

The 35th World Congress of the International Society of Hema

【发表日期】

：

2014年5期

下载到本地 , 更方便阅读

下载此文赞助VIP

声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架

论文部分内容阅读

This study included data from 185 consecutively treated patients,16 years of age or older,who underwent myeloablative transplantation using unrelated UCB (UCBT,n=70) or HLA-identical sibling donor peripheral blood stem cells alone or combined with bone marrow (BMT/PBSCT,n=115) from October 2001 to December 2012.

其他文献

CD8 T cell subsets in patients suffering graft versus host disease after hematopoietic stem cell tra

Introduction Allogeneic hematopoietic stem cell transplantation (HSCT) is a therapy used in regenerative medicine for the recovery of bone marrow function in patients with hematologic diseases.This th

会议

Comparison of unrelated cord blood transplantation and HLA-matched sibling hematopoietic stem cell t

Introduction Few clinical trials were conducted to compare the efficacy and safety of unrelated cord blood transplantation (CBT) and HLA-matched sibling allogeneic hematopoietic stem cell transplantat

会议

Clinical study of allo-HSCT with conditioning regimen containing decitabine in the treatment of adva

Background Allogeneic hematopoietic stem cell transplantation (allo-HSCT) is the only curative treatment options to hematologic malignancies.However,majority of patients with refractory or resistant h

会议

Peripheral blood lymphocyte and monocyte recovery are associated with outcome of hematological malig

Introduction Allogeneic hematopoietic stem cell transplantation (allo-HSCT) is one of the most effective means for curing hematological malignancy.Immunologic reconstitution (IR) posttransplant plays

会议

Co-transplantation of Hematopoietic Stem Cells and Cxcr4 Gene Transduced Mesenchymal Stem Cells Prom

Mesenchymal stem cells (MSCs) are a promising candidate for cellular therapies.Co-transplantation of MSCs and hematopoietic stem cells (HSCs) promotes successful engraftment and improves hematopoietic

会议

An Anti-Human Thymocyte Globulin-Based, Reduced Intensity Conditioning Regimen Before HSCT Is Associ

Reduced intensity (RIT) conditioning regimens whether improve patients quality of life (QoL).Quality of Life Questionnaire analysis showed 35 the RIT patients were able to perform their normal work an

会议

Evaluation of effects of autologous peripheral blood stem cell transplantation on response rate and

Objective To evaluate the response rate and survival rate of refractory or relapsed HL patients treated with autologous peripheral blood stem cell transplantation(APBSCT).Methods From January 2004 to

会议

Objective Umbilical cord blood transplantation (UCBT) has extended the availability of allogeneic HSCT to patients who would not otherwise be eligible for this curative approach because of the lack of

会议

Comparative Analysis of Single-Institute Transplantation From Unrelated Cord Blood and Related Donor

Objective Unrelated donor cord blood transplantation (CBT),as an alternative matched-unrelated or mismatched-related peripheral blood or bone marrow transplantation,has become a widely accepted treatm

会议

Absolute lymphocyte count on day 30 and acute graft-versus-host disease associated with outcomes of

Umbilical cord blood transplantation (UCBT) is increasingly used as an alternative treatment for hematologic malignancies.However,the simple parameters for predicting the outcomes of patients after UC

会议

Similar survival, but better quality of life after myeloablative transplantation using unrelated cor

其他学术论文